Canopy Growth Corp vs Visa Inc — how do they compare? Canopy Growth Corp trades at $1.05 (market cap $421.10M), while Visa Inc trades at $358.55 (market cap $671.74B). The key difference: Visa Inc is far larger — about 1595.2× Canopy Growth Corp's market cap, and Visa Inc pays a 0.74% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| CGC | V | |
|---|---|---|
Market Cap | $421.10M | $671.74B |
Sector | Health | Financials |
52-Week High | $1.92 | $370.47 |
52-Week Low | $0.86 | $295.52 |
Enterprise Value | $378.55M | $682.32B |
Volume | — | 10,431,336 |
Dividend Yield | — | 0.74% |
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $1.02, up 7.13% with a bullish technical signal. The company reported Q1 fiscal 2027 revenue growth of 13% to C$81.2 million and narrowed its EBITDA loss. While revenue trends show stabilization after declining from $520M in 2022 to $269M in 2025, the company continues to post significant net losses with a -222.36% margin. The balance sheet shows improvement with debt-to-asset ratio declining from 53.61% in 2023 to 33.13% in 2025.
CGC presents a high-risk opportunity with potential catalysts from cannabis rescheduling and European expansion. The stock trades below book value (P/B 0.86) but faces substantial execution risks amid persistent losses. Analyst sentiment is mixed with 33% buy ratings, reflecting optimism about restructuring progress versus concerns about profitability timeline.
Visa (V) trades at $358.92, down 0.66% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong Q1 and Q2 2026 earnings beats, with revenue growth from $40B in 2025 to a projected $44.5B in 2026. Analyst consensus is overwhelmingly bullish, with an 85.48% buy rating and a $426.31 price target, suggesting 19% upside. Recent news highlights Visa's AI initiatives, such as Intelligent Commerce Connect, to enhance payment efficiency.
Visa's outlook remains positive due to consistent earnings outperformance, high profit margins, and strategic AI adoption. Risks include rising fintech competition and regulatory pressures. The stock presents a long-term growth opportunity, supported by solid fundamentals and institutional confidence, though investors should monitor competitive and macroeconomic headwinds.
Trailing returns across standard periods
Latest headlines on both assets
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →